These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 37946070)
1. An efficient eco-friendly, simple, and green synthesis of some new spiro-N-(4-sulfamoyl-phenyl)-1,3,4-thiadiazole-2-carboxamide derivatives as potential inhibitors of SARS-CoV-2 proteases: drug-likeness, pharmacophore, molecular docking, and DFT exploration. El-Saghier AM; Enaili SS; Abdou A; Kadry AM Mol Divers; 2024 Feb; 28(1):249-270. PubMed ID: 37946070 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of apigenin-based biflavonoid derivatives as potential therapeutic agents against viral protease (3CLpro) of SARS-CoV-2 via molecular docking, molecular dynamics and quantum mechanics studies. Abdizadeh R; Hadizadeh F; Abdizadeh T J Biomol Struct Dyn; 2023; 41(13):5915-5945. PubMed ID: 35848354 [TBL] [Abstract][Full Text] [Related]
4. Computational Screening Using a Combination of Ligand-Based Machine Learning and Molecular Docking Methods for the Repurposing of Antivirals Targeting the SARS-CoV-2 Main Protease. Yuda GPWC; Hanif N; Hermawan A Daru; 2024 Jun; 32(1):47-65. PubMed ID: 37907683 [TBL] [Abstract][Full Text] [Related]
5. Amentoflavone derivatives significantly act towards the main protease (3CL Dey D; Hossain R; Biswas P; Paul P; Islam MA; Ema TI; Gain BK; Hasan MM; Bibi S; Islam MT; Rahman MA; Kim B Mol Divers; 2023 Apr; 27(2):857-871. PubMed ID: 35639226 [TBL] [Abstract][Full Text] [Related]
6. Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic. Fakhar Z; Faramarzi B; Pacifico S; Faramarzi S J Biomol Struct Dyn; 2021 Oct; 39(16):6171-6183. PubMed ID: 32741312 [TBL] [Abstract][Full Text] [Related]
7. Computational discovery of dual potential inhibitors of SARS-CoV-2 spike/ACE2 and M Bekono BD; Onguéné PA; Simoben CV; Owono LCO; Ntie-Kang F Eur Biophys J; 2024 Aug; 53(5-6):277-298. PubMed ID: 38907013 [TBL] [Abstract][Full Text] [Related]
8. Insight into crystal structures and identification of potential styrylthieno[2,3- El Bakri Y; Ahmad B; Saravanan K; Ahmad I; Bakhite EA; Younis O; Al-Waleedy SAH; Ibrahim OF; Nafady A; Mague JT; Mohamed SK J Biomol Struct Dyn; 2024 May; 42(8):4325-4343. PubMed ID: 37318002 [TBL] [Abstract][Full Text] [Related]
9. Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies. Murali M; Gowtham HG; Shilpa N; Krishnappa HKN; Ledesma AE; Jain AS; Shati AA; Alfaifi MY; Elbehairi SEI; Achar RR; Silina E; Stupin V; Ortega-Castro J; Frau J; Flores-Holguín N; Amruthesh KN; Shivamallu C; Kollur SP; Glossman-Mitnik D Molecules; 2022 Nov; 27(23):. PubMed ID: 36500380 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors - an Ghosh R; Chakraborty A; Biswas A; Chowdhuri S J Biomol Struct Dyn; 2021 Aug; 39(12):4362-4374. PubMed ID: 32568613 [TBL] [Abstract][Full Text] [Related]
14. Identification of potent COVID-19 main protease inhibitors by loading of favipiravir on Mg Al-Shuaeeb RAA; Abd El-Mageed HR; Ahmed SA; Mohamed HS; Hamza ZS; Rafi MO; Rahman MS J Biomol Struct Dyn; 2023; 41(21):11437-11449. PubMed ID: 36591698 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, molecular docking and dynamics studies of pyridazino[4,5- Moghimi P; Sabet-Sarvestani H; Shiri A J Biomol Struct Dyn; 2023; 41(22):13198-13210. PubMed ID: 36951505 [TBL] [Abstract][Full Text] [Related]
16. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation. Choudhary MI; Shaikh M; Tul-Wahab A; Ur-Rahman A PLoS One; 2020; 15(7):e0235030. PubMed ID: 32706783 [TBL] [Abstract][Full Text] [Related]
17. A molecular modelling approach for identifying antiviral selenium-containing heterocyclic compounds that inhibit the main protease of SARS-CoV-2: an in silico investigation. Rakib A; Nain Z; Sami SA; Mahmud S; Islam A; Ahmed S; Siddiqui ABF; Babu SMOF; Hossain P; Shahriar A; Nainu F; Emran TB; Simal-Gandara J Brief Bioinform; 2021 Mar; 22(2):1476-1498. PubMed ID: 33623995 [TBL] [Abstract][Full Text] [Related]
18. Virtual screening and structure-based 3D pharmacophore approach to identify small-molecule inhibitors of SARS-CoV-2 M Elseginy SA J Biomol Struct Dyn; 2022; 40(24):13658-13674. PubMed ID: 34676801 [TBL] [Abstract][Full Text] [Related]